A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Publication date: Available online 18 June 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Dandan Sun, Yifang Zou, Liu Song, Shulan Han, Hao Yang, Di Chu, Yun Dai, Jie Ma, Caitriona M. O’Driscoll, Zhuo Yu, Jianfeng Guo
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research